STAAR Surgical Co
F:SR3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
STAAR Surgical Co
F:SR3
|
US |
|
O
|
Olin Corp
F:OLN
|
US |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
UiPath Inc
NYSE:PATH
|
US |
|
ProPetro Holding Corp
F:2PG
|
US |
Intrinsic Value
Is SR3 undervalued or overvalued?
See the intrinsic value estimate for 
STAAR Surgical Co and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SR3 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with SR3’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What STAAR Surgical Does
STAAR Surgical makes implantable lenses for the eye, mainly used to correct nearsightedness and astigmatism. Its core product is a Collamer lens that an eye surgeon places inside the eye, giving patients a vision-correction option that does not reshape the cornea like LASIK.
- Headquarters
- United States of America US
- Employees
- 921
- IPO date
- Feb 24, 1992
Revenue & Expenses Breakdown
STAAR Surgical Co
Earnings Waterfall
STAAR Surgical Co
The intrinsic value for STAAR Surgical Co (SR3) under the Base Case is hidden EUR.
Compared with the current market price of 19.215 EUR, the stock appears hidden.